|
NL218146A
(enExample)
|
1956-02-13 |
1900-01-01 |
|
|
|
BE787580A
(fr)
|
1971-08-13 |
1973-02-14 |
Hoechst Ag |
Procede de preparation de derives du furanne
|
|
BE787576A
(fr)
|
1971-08-13 |
1973-02-14 |
Hoechst Ag |
Derives de benzofuranne et leur utilisation comme azureurs optiques
|
|
GB1409865A
(en)
|
1973-02-13 |
1975-10-15 |
Science Union & Cie |
Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
|
|
GB1593417A
(en)
|
1976-12-22 |
1981-07-15 |
Squibb & Sons Inc |
Carbocyclic-fused pyrazolopyridine derivatives
|
|
US4062858A
(en)
|
1976-12-22 |
1977-12-13 |
E. R. Squibb & Sons, Inc. |
Derivatives of 5,6-dihydrobenzo[5,6]cyclohepta[1,2-b]pyrazolo[4,3-e]pyridin-11(1H)-ones and 11(1H)-imines
|
|
EP0010063B1
(de)
|
1978-10-04 |
1982-12-29 |
Ciba-Geigy Ag |
Verfahren zur Herstellung von Furanyl-benzazolen
|
|
DE2853765A1
(de)
|
1978-12-13 |
1980-06-26 |
Bayer Ag |
Verfahren zur herstellung von benzimidazolylbenzofuranen
|
|
DE2904829A1
(de)
|
1979-02-08 |
1980-08-14 |
Bayer Ag |
Verfahren zur herstellung von benzimidazolylbenzofuran
|
|
GB2053218B
(en)
|
1979-06-29 |
1984-01-25 |
Wellcome Found |
Pharmaceutical ethers of 2,6-dihydroxybenzaldehyde
|
|
DE3175083D1
(en)
|
1980-12-18 |
1986-09-11 |
Wellcome Found |
Pharmaceutical compounds, their preparation and use
|
|
JPS5929667A
(ja)
|
1982-08-13 |
1984-02-16 |
Otsuka Pharmaceut Co Ltd |
カルボスチリル誘導体および強心剤
|
|
US4478834A
(en)
|
1983-02-11 |
1984-10-23 |
Usv Pharmaceutical Corporation |
Dihydropyridines and their use in the treatment of asthma
|
|
GB8402740D0
(en)
|
1984-02-02 |
1984-03-07 |
Scras |
Furo-(3 4-c)-pyridine derivatives
|
|
JPS6140236A
(ja)
|
1984-08-02 |
1986-02-26 |
Yamanouchi Pharmaceut Co Ltd |
ハイドロキノン誘導体
|
|
DE3431004A1
(de)
|
1984-08-23 |
1986-03-06 |
Hoechst Ag, 6230 Frankfurt |
Neue 3-pyridylverbindungen und verfahren zu ihrer herstellung
|
|
DD226590A1
(de)
|
1984-09-07 |
1985-08-28 |
Univ Leipzig |
Mittel zur phagenhemmung in mikrobiellen produktionsprozessen
|
|
GB8603475D0
(en)
|
1986-02-12 |
1986-03-19 |
Glaxo Group Ltd |
Chemical compounds
|
|
DK111387A
(da)
|
1986-03-05 |
1987-09-06 |
Otsuka Pharma Co Ltd |
Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
|
|
US4831041A
(en)
|
1986-11-26 |
1989-05-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Imidazopyridine compounds and processes for preparation thereof
|
|
AU598093B2
(en)
|
1987-02-07 |
1990-06-14 |
Wellcome Foundation Limited, The |
Pyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof
|
|
DD258226A1
(de)
|
1987-03-05 |
1988-07-13 |
Fahlberg List Veb |
Verfahren zur herstellung von aroxymethylchinoxalinen
|
|
JPH07121937B2
(ja)
|
1987-03-18 |
1995-12-25 |
大塚製薬株式会社 |
カルボスチリル誘導体
|
|
JPS63258463A
(ja)
|
1987-04-14 |
1988-10-25 |
Kumiai Chem Ind Co Ltd |
２−フエノキシピリミジン誘導体及び除草剤
|
|
GB8711802D0
(en)
|
1987-05-19 |
1987-06-24 |
Fujisawa Pharmaceutical Co |
Dithioacetal compounds
|
|
GB8718940D0
(en)
|
1987-08-11 |
1987-09-16 |
Glaxo Group Ltd |
Chemical compounds
|
|
US4920131A
(en)
|
1987-11-03 |
1990-04-24 |
Rorer Pharmaceutical Corp. |
Quinoline derivatives and use thereof as antagonists of leukotriene D4
|
|
JP2650038B2
(ja)
|
1988-01-27 |
1997-09-03 |
サントリー株式会社 |
ピロリチジン化合物およびその用途
|
|
JPH01305081A
(ja)
|
1988-04-04 |
1989-12-08 |
E R Squibb & Sons Inc |
３―アシルアミノ―１―［［［（置換スルホニル）アミノ〕カルボニル〕アミノ〕―２―アゼチジノン類
|
|
US4952574A
(en)
|
1988-09-26 |
1990-08-28 |
Riker Laboratories, Inc. |
Antiarrhythmic substituted N-(2-piperidylmethyl)benzamides
|
|
IE81170B1
(en)
|
1988-10-21 |
2000-05-31 |
Zeneca Ltd |
Pyridine derivatives
|
|
DD276480A1
(de)
|
1988-10-26 |
1990-02-28 |
Fahlberg List Veb |
Verfahren zur herstellung von naphtho/2,1-b/fur-2-ylchinoxalinen
|
|
DD276479A1
(de)
|
1988-10-26 |
1990-02-28 |
Fahlberg List Veb |
Verfahren zur herstellung von benzo/b/fur-2-ylchinoxalinen
|
|
US5236917A
(en)
|
1989-05-04 |
1993-08-17 |
Sterling Winthrop Inc. |
Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
|
|
IT1230859B
(it)
|
1989-06-05 |
1991-11-08 |
Corvi Camillo Spa |
2 alchinilfenoli sostituiti ad azione anti infiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
|
|
GB2244054B
(en)
|
1990-04-19 |
1994-04-06 |
Ici Plc |
Pyridine derivatives
|
|
NZ238576A
(en)
|
1990-06-18 |
1994-12-22 |
Merck & Co Inc |
Pyridinone derivatives, preparation and pharmaceutical compositions thereof
|
|
CA2051705A1
(en)
|
1990-06-19 |
1991-12-20 |
Kiyoaki Katano |
Pyridine derivatives having angiotensin ii antagonism
|
|
NL9001752A
(nl)
|
1990-08-02 |
1992-03-02 |
Cedona Pharm Bv |
Nieuwe 1,4-dihydropyridinederivaten.
|
|
IL99731A0
(en)
|
1990-10-18 |
1992-08-18 |
Merck & Co Inc |
Hydroxylated pyridine derivatives,their preparation and pharmaceutical compositions containing them
|
|
JPH05301872A
(ja)
|
1992-04-23 |
1993-11-16 |
Kumiai Chem Ind Co Ltd |
ピコリン酸誘導体及び除草剤
|
|
US5403816A
(en)
|
1990-10-25 |
1995-04-04 |
Kumiai Chemical Industry Co., Ltd. |
Picolinic acid derivative and herbicidal composition
|
|
WO1992013841A1
(de)
|
1991-02-08 |
1992-08-20 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Komplexbildner
|
|
JPH0641118A
(ja)
|
1991-05-31 |
1994-02-15 |
Kumiai Chem Ind Co Ltd |
ピコリン酸誘導体及び除草剤
|
|
US5185251A
(en)
|
1991-06-07 |
1993-02-09 |
Merck & Co., Inc. |
Microbial transformation of a substituted pyridinone using actinoplanacete sp. MA 6559
|
|
JP2600644B2
(ja)
|
1991-08-16 |
1997-04-16 |
藤沢薬品工業株式会社 |
チアゾリルベンゾフラン誘導体
|
|
FR2680512B1
(fr)
|
1991-08-20 |
1995-01-20 |
Adir |
Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
|
US5202243A
(en)
|
1991-10-04 |
1993-04-13 |
Merck & Co., Inc. |
Method of hydroxylating 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methyl-2-(1H)-pyridinone by incubation with liver slices
|
|
GB9203798D0
(en)
|
1992-02-21 |
1992-04-08 |
Fujisawa Pharmaceutical Co |
Quinolylbenzofuran derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
|
|
EP0648209A1
(de)
|
1992-07-01 |
1995-04-19 |
Byk Gulden Lomberg Chemische Fabrik GmbH |
Kontrastmittel für die mr diagnostik
|
|
US5290941A
(en)
|
1992-10-14 |
1994-03-01 |
Merck & Co., Inc. |
Facile condensation of methylbenzoxazoles with aromatic aldehydes
|
|
HU224548B1
(hu)
|
1993-04-07 |
2005-10-28 |
Taiho Pharmaceutical Co. Ltd. |
Tiazolidinszármazékok és ezeket tartalmazó gyógyszerkészítmények, valamint eljárás előállításukra
|
|
DE4318550A1
(de)
|
1993-06-04 |
1994-12-08 |
Boehringer Mannheim Gmbh |
Aryliden-4-oxo-2-thioxo-3- thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
IL110151A
(en)
|
1993-06-30 |
1998-10-30 |
Sankyo Co |
Amide derivatives and pharmaceutical compositions containing them
|
|
JPH0725882A
(ja)
|
1993-07-07 |
1995-01-27 |
Res Dev Corp Of Japan |
アクロメリン酸ｂおよびｅを製造するための中間体と、その製造方法
|
|
ES2132284T3
(es)
|
1993-08-05 |
1999-08-16 |
Hoechst Marion Roussel Inc |
Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa.
|
|
EP0640609A1
(en)
|
1993-08-24 |
1995-03-01 |
Ono Pharmaceutical Co., Ltd. |
Fused phenol derivatives having inhibitory activity on TXA2 synthetase, and 5-lipoxygenase and scavenging activity on oxygen species
|
|
US5965566A
(en)
|
1993-10-20 |
1999-10-12 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
|
US5880131A
(en)
|
1993-10-20 |
1999-03-09 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
|
US5840900A
(en)
|
1993-10-20 |
1998-11-24 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
|
US5605976A
(en)
|
1995-05-15 |
1997-02-25 |
Enzon, Inc. |
Method of preparing polyalkylene oxide carboxylic acids
|
|
WO1995014015A1
(en)
|
1993-11-19 |
1995-05-26 |
Ciba-Geigy Ag |
Benzothiophene derivatives possessing a methoxyimino substituent as microbicides
|
|
EP0658559A1
(de)
|
1993-12-14 |
1995-06-21 |
Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. |
Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren
|
|
ATE191485T1
(de)
|
1994-02-14 |
2000-04-15 |
Merrell Pharma Inc |
Mercaptoacetylamid-1,3,4,5- tetrahydrobenzo(c)azepin-3-ein disulfidderivate als enkephalinase und ace inhibitoren
|
|
GB9420557D0
(en)
|
1994-10-12 |
1994-11-30 |
Zeneca Ltd |
Aromatic compounds
|
|
DE4442050A1
(de)
|
1994-11-25 |
1996-05-30 |
Hoechst Ag |
Heterospiroverbindungen und ihre Verwendung als Elektrolumineszenzmaterialien
|
|
US5650408A
(en)
|
1995-06-07 |
1997-07-22 |
Karanewsky; Donald S. |
Thiazolo benzazepine containing dual action inhibitors
|
|
TW434240B
(en)
|
1995-06-20 |
2001-05-16 |
Zeneca Ltd |
Aromatic compounds, preparation thereof and pharmaceutical composition comprising same
|
|
JP3895404B2
(ja)
|
1996-05-17 |
2007-03-22 |
興和株式会社 |
カルコン誘導体及びこれを含有する医薬
|
|
EP0923580A1
(en)
|
1996-07-26 |
1999-06-23 |
Dr. Reddy's Research Foundation |
Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
|
|
WO1998008818A1
(en)
|
1996-08-26 |
1998-03-05 |
Genetics Institute, Inc. |
Inhibitors of phospholipase enzymes
|
|
US6630496B1
(en)
|
1996-08-26 |
2003-10-07 |
Genetics Institute Llc |
Inhibitors of phospholipase enzymes
|
|
WO1998009967A1
(fr)
|
1996-09-09 |
1998-03-12 |
Kyowa Hakko Kogyo Co., Ltd. |
Derives de pyrrolocarbazole
|
|
JP2001503762A
(ja)
|
1996-11-12 |
2001-03-21 |
ノバルティス アクチェンゲゼルシャフト |
除草剤として有用なピラゾール誘導体
|
|
US6043389A
(en)
|
1997-03-11 |
2000-03-28 |
Mor Research Applications, Ltd. |
Hydroxy and ether-containing oxyalkylene esters and uses thereof
|
|
FR2761687B1
(fr)
|
1997-04-08 |
2000-09-15 |
Centre Nat Rech Scient |
Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
|
|
US5760232A
(en)
|
1997-06-16 |
1998-06-02 |
Schering Corporation |
Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds
|
|
US6214817B1
(en)
|
1997-06-20 |
2001-04-10 |
Monsanto Company |
Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
|
|
US6011042A
(en)
|
1997-10-10 |
2000-01-04 |
Enzon, Inc. |
Acyl polymeric derivatives of aromatic hydroxyl-containing compounds
|
|
US6111107A
(en)
|
1997-11-20 |
2000-08-29 |
Enzon, Inc. |
High yield method for stereoselective acylation of tertiary alcohols
|
|
CN1294590A
(zh)
|
1997-12-12 |
2001-05-09 |
欧罗赛铁克股份有限公司 |
通过2－硫代黄嘌呤制备3－取代腺嘌呤的方法
|
|
EA200000873A1
(ru)
|
1998-02-25 |
2001-04-23 |
Дженетикс Инститьют, Инк. |
Ингибиторы фосфолипазы a
|
|
WO1999047529A1
(en)
|
1998-03-18 |
1999-09-23 |
Ariad Pharmaceuticals, Inc. |
Heterocyclic signal transduction inhibitors, compositions containing them
|
|
US6214879B1
(en)
|
1998-03-24 |
2001-04-10 |
Virginia Commonwealth University |
Allosteric inhibitors of pyruvate kinase
|
|
US6153655A
(en)
|
1998-04-17 |
2000-11-28 |
Enzon, Inc. |
Terminally-branched polymeric linkers and polymeric conjugates containing the same
|
|
GB9810860D0
(en)
|
1998-05-20 |
1998-07-22 |
Hoechst Schering Agrevo Gmbh |
Substituted pyridine and pyrimidines, processes for their preparation and their use as pesticides
|
|
CA2333770A1
(en)
|
1998-06-04 |
1999-12-09 |
Abbott Laboratories |
Cell adhesion-inhibiting antinflammatory compounds
|
|
US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
GB9818627D0
(en)
|
1998-08-26 |
1998-10-21 |
Glaxo Group Ltd |
Improvements in dva vaccination
|
|
GB9823871D0
(en)
|
1998-10-30 |
1998-12-23 |
Pharmacia & Upjohn Spa |
2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
|
|
US20030060425A1
(en)
|
1998-11-24 |
2003-03-27 |
Ahlem Clarence N. |
Immune modulation method using steroid compounds
|
|
ID29066A
(id)
|
1998-12-14 |
2001-07-26 |
Hoffmann La Roche |
Turunan fenilglisina
|
|
US6544980B2
(en)
|
1998-12-31 |
2003-04-08 |
Aventis Pharmaceuticals Inc. |
N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
|
|
WO2000040564A1
(en)
|
1998-12-31 |
2000-07-13 |
Aventis Pharmaceuticals Inc. |
N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
|
|
US6472349B1
(en)
|
1999-03-31 |
2002-10-29 |
Basf Aktiengesellschaft |
Pyridine-2,3-dicarboxylic acid diamides
|
|
US6251927B1
(en)
|
1999-04-20 |
2001-06-26 |
Medinox, Inc. |
Methods for treatment of sickle cell anemia
|
|
MXPA01011502A
(es)
|
1999-05-14 |
2003-08-20 |
Boehringer Ingelheim Pharma |
Compuestos de tipo profarmaco anti-tumorigenos, activados por enzimas.
|
|
US6184228B1
(en)
|
1999-05-25 |
2001-02-06 |
Anadys Pharmaceuticals, Inc. |
Anti-sickling agents: selection methods and effective compounds
|
|
WO2000075145A1
(en)
|
1999-06-03 |
2000-12-14 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
AUPQ105499A0
(en)
|
1999-06-18 |
1999-07-08 |
Biota Scientific Management Pty Ltd |
Antiviral agents
|
|
WO2001000612A2
(en)
|
1999-06-28 |
2001-01-04 |
Janssen Pharmaceutica N.V. |
Respiratory syncytial virus replication inhibitors
|
|
BR0014331A
(pt)
|
1999-09-28 |
2003-06-10 |
Eisai Co Ltd |
Composto, inibidor de enzima sintetizadora de esqualeno, composição medicinal, processo para produção de um composto quinuclidìnico e processo para prevenção ou cura de uma doença
|
|
CN1384814B
(zh)
|
1999-11-05 |
2015-11-25 |
艾米斯菲尔技术有限公司 |
用于送递活性剂的苯氧基羧酸化合物和组合物
|
|
AUPQ407699A0
(en)
|
1999-11-16 |
1999-12-09 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
|
WO2001057044A1
(en)
|
2000-02-01 |
2001-08-09 |
Daiichi Pharmaceutical Co., Ltd. |
Pyridoxazine derivatives
|
|
US6506755B2
(en)
|
2000-02-03 |
2003-01-14 |
Hoffmann-La Roche Inc. |
Thiazolidinecarboxyl acids
|
|
AUPQ585000A0
(en)
|
2000-02-28 |
2000-03-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
|
US6649172B2
(en)
|
2000-03-17 |
2003-11-18 |
Corixa Corporation |
Amphipathic aldehydes and their uses as adjuvants and immunoeffectors
|
|
AUPQ841300A0
(en)
|
2000-06-27 |
2000-07-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New aminoalcohol derivatives
|
|
DK1303490T3
(da)
|
2000-07-14 |
2008-08-25 |
Hoffmann La Roche |
N-oxider som NK1-receptorantagoniskprodugs af 4-phenyl-pyridinderivater
|
|
US20020142995A1
(en)
|
2000-08-01 |
2002-10-03 |
Nicolau Yves Claude |
Ammonium salts of hemoglobin allosteric effectors, and uses thereof
|
|
US6653313B2
(en)
|
2000-08-10 |
2003-11-25 |
Warner-Lambert Company Llc |
1,4-dihydropyridine compounds as bradykinin antagonists
|
|
JP4272338B2
(ja)
|
2000-09-22 |
2009-06-03 |
バイエル アクチェンゲゼルシャフト |
ピリジン誘導体
|
|
AUPR034000A0
(en)
|
2000-09-25 |
2000-10-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
|
JPWO2002051849A1
(ja)
|
2000-12-26 |
2004-04-22 |
第一製薬株式会社 |
Ｃｄｋ４活性阻害剤
|
|
DE60139025D1
(de)
|
2000-12-28 |
2009-07-30 |
Takeda Pharmaceutical |
Alkansäurederivate, verfahren zu deren herstellung und deren verwendung
|
|
GB0102595D0
(en)
|
2001-02-01 |
2001-03-21 |
Virk Kuldip |
Smart solar
|
|
US20030022923A1
(en)
|
2001-03-01 |
2003-01-30 |
Medinox, Inc. |
Methods for treatment of sickle cell anemia
|
|
US6627646B2
(en)
|
2001-07-17 |
2003-09-30 |
Sepracor Inc. |
Norastemizole polymorphs
|
|
WO2003009807A2
(en)
|
2001-07-23 |
2003-02-06 |
Galileo Laboratories, Inc. |
Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
|
|
JP2003075970A
(ja)
|
2001-08-31 |
2003-03-12 |
Konica Corp |
ハロゲン化銀カラー写真感光材料、カラー写真感光材料、その画像形成方法及びデジタル画像情報作製方法
|
|
KR100467313B1
(ko)
|
2001-11-22 |
2005-01-24 |
한국전자통신연구원 |
적색 유기 전기발광 화합물 및 그 제조 방법과 전기발광소자
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
WO2003053368A2
(en)
|
2001-12-19 |
2003-07-03 |
Atherogenics, Inc. |
Chalcone derivatives and their use to treat diseases
|
|
US20030190333A1
(en)
|
2002-02-04 |
2003-10-09 |
Corixa Corporation |
Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
|
|
AU2003230985A1
(en)
|
2002-04-18 |
2003-11-03 |
Stephen H. Embury |
Method and composition for preventing pain in sickle cell patients
|
|
US6608076B1
(en)
|
2002-05-16 |
2003-08-19 |
Enzon, Inc. |
Camptothecin derivatives and polymeric conjugates thereof
|
|
GB0212785D0
(en)
|
2002-05-31 |
2002-07-10 |
Glaxo Group Ltd |
Compounds
|
|
CA2493908A1
(en)
|
2002-08-08 |
2004-02-19 |
Smithkline Beecham Corporation |
Thiophene compounds
|
|
AU2003257666A1
(en)
|
2002-08-23 |
2004-03-11 |
Kirin Beer Kabushiki Kaisha |
COMPOUND HAVING TGFss INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME
|
|
WO2004024705A1
(ja)
|
2002-09-10 |
2004-03-25 |
Takeda Pharmaceutical Company Limited |
５員複素環化合物
|
|
PT1567490E
(pt)
|
2002-12-04 |
2011-12-09 |
Univ Virginia Commonwealth |
Agentes contra a falciformação
|
|
WO2004056727A2
(en)
|
2002-12-19 |
2004-07-08 |
Atherogenics, Inc. |
Process of making chalcone derivatives
|
|
US7655633B2
(en)
|
2002-12-25 |
2010-02-02 |
Kissei Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic derivatives, medicinal compositions containing the same and medicinal use thereof
|
|
EP1596818B1
(de)
|
2003-02-24 |
2006-05-03 |
Randolph Dr. Dr. Prof. Riemschneider |
Kosmetische zusammensetzung mit whitening-effekt, verfahren zu ihrer herstellung und ihre verwendung
|
|
US20040186077A1
(en)
|
2003-03-17 |
2004-09-23 |
Medicure International Inc. |
Novel heteroaryl phosphonates as cardioprotective agents
|
|
ZA200507752B
(en)
|
2003-03-28 |
2007-01-31 |
Threshold Pharmaceuticals Inc |
Compositions and methods for treating cancer
|
|
US7291631B2
(en)
|
2003-04-11 |
2007-11-06 |
Genzyme Corporation |
CXCR4 chemokine receptor binding compounds
|
|
EP1636205A1
(en)
|
2003-06-12 |
2006-03-22 |
Novo Nordisk A/S |
Pyridinyl carbamates as hormone-sensitive lipase inhibitors
|
|
WO2005019220A2
(en)
|
2003-08-11 |
2005-03-03 |
Cellular Genomics Inc. |
Substituted imidazo[1,2-a]pyrazines as modulators of kinase activity
|
|
US7411083B2
(en)
|
2003-09-25 |
2008-08-12 |
Wyeth |
Substituted acetic acid derivatives
|
|
EP1682508A1
(en)
|
2003-11-05 |
2006-07-26 |
F. Hoffmann-La Roche Ag |
Phenyl derivatives as ppar agonists
|
|
RU2006120084A
(ru)
|
2003-11-10 |
2008-01-10 |
Шеринг Акциенгезельшафт (De) |
Бензилэфирамины, полезные как антагонисты ccr-5
|
|
KR20110116225A
(ko)
|
2003-12-02 |
2011-10-25 |
셀진 코포레이션 |
혈색소병증 및 빈혈의 치료 및 관리를 위한 방법및 조성물
|
|
US7378439B2
(en)
|
2004-01-20 |
2008-05-27 |
Usv, Ltd. |
Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
|
|
AU2005211349A1
(en)
|
2004-01-30 |
2005-08-18 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
N-benzyl-3,4-dihyroxypyridine-2-carboxamide and N-benzyl-2,3-dihydroxypyridine-4-carboxamide compounds useful as HIV integrase inhibitors
|
|
GB0403038D0
(en)
|
2004-02-11 |
2004-03-17 |
Novartis Ag |
Organic compounds
|
|
WO2005087766A1
(en)
|
2004-03-09 |
2005-09-22 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Hiv integrase inhibitors
|
|
US20080132458A1
(en)
|
2004-03-10 |
2008-06-05 |
Threshold Pharmaceuticals, Inc. |
Hypoxia-Activated Anti-Cancer Agents
|
|
DE102004015226B3
(de)
|
2004-03-24 |
2005-08-25 |
Siemens Ag |
Verfahren zum Plasmareinigen eines Werkstücks und zu dessen Durchführung geeignete Vorrichtung
|
|
US7847120B2
(en)
|
2004-04-22 |
2010-12-07 |
Virginia Commonwealth University Intellectual Property Foundation |
Compositions of allosteric hemoglobin modifiers and methods of making the same
|
|
TW200606133A
(en)
|
2004-06-30 |
2006-02-16 |
Sankyo Co |
Substituted benzene compounds
|
|
TW200606129A
(en)
|
2004-07-26 |
2006-02-16 |
Chugai Pharmaceutical Co Ltd |
Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
EP1817288A4
(en)
|
2004-10-28 |
2009-08-26 |
Medicure Int Inc |
DUAL ANTIPLÄTTCHEN / ANTIKOAGULANS PYRIDOXINANALOGE
|
|
EP1831170A4
(en)
|
2004-12-14 |
2009-10-14 |
Astrazeneca Ab |
SUBSTITUTED AMINOPYRIDINES AND THEIR USE
|
|
JP5317257B2
(ja)
|
2005-02-21 |
2013-10-16 |
塩野義製薬株式会社 |
Ｈｉｖインテグラーゼ阻害活性を有する２環性カルバモイルピリドン誘導体
|
|
JP4874958B2
(ja)
|
2005-03-30 |
2012-02-15 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ピリジン誘導体を含有する抗真菌剤
|
|
GB0506677D0
(en)
|
2005-04-01 |
2005-05-11 |
Btg Int Ltd |
Iron modulators
|
|
PL3372281T3
(pl)
|
2005-04-28 |
2021-12-27 |
Viiv Healthcare Company |
Policykliczne pochodne karbamoilopirydonu o aktywności inhibitorowej wobec integrazy HIV
|
|
DE102005025989A1
(de)
|
2005-06-07 |
2007-01-11 |
Bayer Cropscience Ag |
Carboxamide
|
|
JP2006342115A
(ja)
|
2005-06-10 |
2006-12-21 |
Shionogi & Co Ltd |
Ｈｉｖインテグラーゼ阻害活性を有する多環性化合物
|
|
AU2006264649A1
(en)
|
2005-06-30 |
2007-01-11 |
Prosidion Limited |
GPCR agonists
|
|
CN100562514C
(zh)
|
2005-07-22 |
2009-11-25 |
中国科学院上海药物研究所 |
一类取代丙酰胺衍生物、其制备方法和用途
|
|
GB0516270D0
(en)
|
2005-08-08 |
2005-09-14 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2007047204A1
(en)
|
2005-10-11 |
2007-04-26 |
University Of Pittsburgh |
Isotopically-labeled benzofuran compounds as imagingagents foramyloidogenic proteins
|
|
WO2007049675A1
(ja)
|
2005-10-27 |
2007-05-03 |
Shionogi & Co., Ltd. |
Ｈｉｖインテグラーゼ阻害活性を有する多環性カルバモイルピリドン誘導体
|
|
JP2009515997A
(ja)
|
2005-11-18 |
2009-04-16 |
タケダ サン ディエゴ インコーポレイテッド |
グルコキナーゼ活性剤
|
|
EP1976851A2
(en)
|
2006-01-17 |
2008-10-08 |
Neurocrine Biosciences, Inc. |
Phenoxy-substituted pyrimidines as adenosine receptor antagonists
|
|
RU2318818C1
(ru)
|
2006-04-12 |
2008-03-10 |
Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" |
Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты)
|
|
GB0614586D0
(en)
|
2006-07-22 |
2006-08-30 |
Pliva Istrazivacki Inst D O O |
Pharmaceutical Formulation
|
|
CN101113148A
(zh)
|
2006-07-26 |
2008-01-30 |
中国海洋大学 |
二氧哌嗪类化合物及其制备方法和用途
|
|
CA2658925C
(en)
|
2006-07-27 |
2015-07-14 |
Amorepacific Corporation |
Novel sulfonylamino acrylamide derivatives, isomer thereof,or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
|
|
TW200817424A
(en)
|
2006-08-04 |
2008-04-16 |
Daiichi Sankyo Co Ltd |
Benzylphenyl glucopyranoside derivatives
|
|
TWI389895B
(zh)
|
2006-08-21 |
2013-03-21 |
Infinity Discovery Inc |
抑制ｂｃｌ蛋白質與結合夥伴間之交互作用的化合物及方法
|
|
PL2061749T3
(pl)
|
2006-09-03 |
2018-11-30 |
Techfields Biochem Co. Ltd |
Dodatnio naładowane, rozpuszczalne w wodzie proleki acetaminofenu i związków pokrewnych o bardzo dużej szybkości przenikania przez skórę
|
|
AU2007303846B2
(en)
|
2006-10-04 |
2011-03-10 |
Pfizer Products Inc. |
Pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as calcium receptor antagonists
|
|
EP2097385B1
(en)
|
2006-10-23 |
2012-08-01 |
Merck Sharp & Dohme Corp. |
2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
|
|
FR2909379B1
(fr)
|
2006-11-30 |
2009-01-16 |
Servier Lab |
Nouveaux derives heterocycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
|
TW200835687A
(en)
|
2006-11-30 |
2008-09-01 |
R Tech Ueno Ltd |
Thiazole derivatives and their use as VAP-1 inhibitor
|
|
CN101558038B
(zh)
|
2006-11-30 |
2013-05-01 |
国立大学法人东京工业大学 |
姜黄素衍生物
|
|
JP2008137914A
(ja)
|
2006-11-30 |
2008-06-19 |
Rikogaku Shinkokai |
β−セクレターゼ阻害剤
|
|
EP2125734A2
(en)
|
2007-02-22 |
2009-12-02 |
Syngeta Participations AG |
Novel microbiocides
|
|
TWI407960B
(zh)
|
2007-03-23 |
2013-09-11 |
Jerini Ag |
小分子緩激肽ｂ２受體調節劑
|
|
US7994367B2
(en)
|
2007-05-22 |
2011-08-09 |
Sumitomo Chemical Company, Limited |
Method for producing benzaldehyde compound
|
|
WO2009001214A2
(en)
|
2007-06-28 |
2008-12-31 |
Pfizer Products Inc. |
Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists
|
|
US20090069288A1
(en)
|
2007-07-16 |
2009-03-12 |
Breinlinger Eric C |
Novel therapeutic compounds
|
|
KR101158191B1
(ko)
|
2007-07-17 |
2012-06-19 |
에프. 호프만-라 로슈 아게 |
11ｂ-하이드록시스테로이드 탈수소효소의 억제제
|
|
CN101765442B
(zh)
|
2007-07-26 |
2014-09-17 |
诺华股份有限公司 |
有机化合物
|
|
TW200918521A
(en)
|
2007-08-31 |
2009-05-01 |
Astrazeneca Ab |
Heterocyclic amides and methods of use thereof
|
|
BRPI0817434A2
(pt)
|
2007-10-17 |
2015-06-16 |
Novartis Ag |
Composto orgânicos
|
|
KR20120102117A
(ko)
|
2007-12-04 |
2012-09-17 |
에프. 호프만-라 로슈 아게 |
아이속사졸로-피리딘 유도체
|
|
US7776875B2
(en)
|
2007-12-19 |
2010-08-17 |
Hoffman-La Roche Inc. |
Spiroindolinone derivatives
|
|
JP2009203230A
(ja)
|
2008-01-31 |
2009-09-10 |
Daiichi Sankyo Co Ltd |
ベンジルフェニルグルコピラノシド誘導体を含有する医薬組成物
|
|
WO2009101898A1
(ja)
|
2008-02-14 |
2009-08-20 |
Sumitomo Chemical Company, Limited |
ベンズアルデヒド化合物の製造方法
|
|
BRPI0906348A2
(pt)
|
2008-04-11 |
2019-07-16 |
Inst Of Medicinal Molecular Designer Inc |
composto representado pela fórmula (1), composição farmacêutica; inibidor pai-1 e medicamento para prevenção para prevenção e/ou tratamento terapêutico de doença causada pela manifestação de pai-1 ou pelo aumento da ação de pai-1
|
|
US8633245B2
(en)
|
2008-04-11 |
2014-01-21 |
Institute Of Medicinal Molecular Design, Inc. |
PAI-1 inhibitor
|
|
JP2011136906A
(ja)
|
2008-04-18 |
2011-07-14 |
Otsuka Pharmaceut Co Ltd |
複素環化合物
|
|
US8119647B2
(en)
|
2008-04-23 |
2012-02-21 |
Glenmark Pharmaceuticals S.A. |
Fused pyrimidineone compounds as TRPV3 modulators
|
|
KR101538822B1
(ko)
|
2008-05-08 |
2015-07-22 |
노바 사우쓰이스턴 유니버시티 |
혈관 내피 성장 인자 수용체에 대한 특이적 억제제
|
|
RU2010153656A
(ru)
|
2008-06-04 |
2012-07-20 |
Амбрилиа Байофарма Инк. (Ca) |
Ингибиторы интегразы вич из пиридоксина
|
|
DE102008027574A1
(de)
|
2008-06-10 |
2009-12-17 |
Merck Patent Gmbh |
Neue Pyrrolidinderivate als MetAP-2 Inhibitoren
|
|
JP5314330B2
(ja)
|
2008-06-16 |
2013-10-16 |
住友化学株式会社 |
２−（アリールオキシメチル）ベンズアルデヒドの製造方法およびその中間体
|
|
GB0811451D0
(en)
|
2008-06-20 |
2008-07-30 |
Syngenta Participations Ag |
Novel microbiocides
|
|
AR073304A1
(es)
|
2008-09-22 |
2010-10-28 |
Jerini Ag |
Moduladores del receptor de bradiquinina b2 de molecula pequena
|
|
US8815875B2
(en)
|
2008-11-12 |
2014-08-26 |
Merck Sharp & Dohme Corp. |
Inhibitors of fatty acid binding protein (FABP)
|
|
JP2010168314A
(ja)
*
|
2009-01-23 |
2010-08-05 |
Daiichi Sankyo Co Ltd |
ベンゼン化合物の製造のための中間体およびその製造方法
|
|
TW201033201A
(en)
|
2009-02-19 |
2010-09-16 |
Hoffmann La Roche |
Isoxazole-isoxazole and isoxazole-isothiazole derivatives
|
|
EP2732818B1
(en)
|
2009-03-31 |
2017-05-03 |
Ligand Pharmaceuticals Inc. |
A biphenylsulfonamide endothelin and angiotensin ii receptor antagonist to treat glomerulosclerosis
|
|
WO2010129055A1
(en)
|
2009-05-08 |
2010-11-11 |
Tetraphase Pharmaceuticals, Inc. |
8-aza tetracycline compounds
|
|
EP2471789B9
(en)
|
2009-08-26 |
2015-03-25 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic ring derivative and use thereof
|
|
EP2474540A4
(en)
|
2009-08-31 |
2013-03-13 |
Nippon Chemiphar Co |
GPR119 AGONIST
|
|
AU2010297290A1
(en)
|
2009-09-21 |
2012-03-15 |
F. Hoffmann-La Roche Ag |
Heterocyclic antiviral compounds
|
|
FI2498756T4
(fi)
|
2009-11-09 |
2023-03-22 |
|
Neratinibimaleaatin tablettiformulaatiot
|
|
TW201139406A
(en)
|
2010-01-14 |
2011-11-16 |
Glaxo Group Ltd |
Voltage-gated sodium channel blockers
|
|
KR101698153B1
(ko)
|
2010-04-26 |
2017-01-23 |
광주과학기술원 |
Ｐ2ｘ1 및 ｐ2ｘ3 수용체 길항제로 사용되는 신규한 피리딘 카르복실산계 화합물, 이의 제조방법 및 이를 포함하는 조성물
|
|
CN102232949A
(zh)
|
2010-04-27 |
2011-11-09 |
孙远 |
提高药物溶出度的组合物及其制备方法
|
|
TWI535442B
(zh)
|
2010-05-10 |
2016-06-01 |
Kyowa Hakko Kirin Co Ltd |
A nitrogen-containing heterocyclic compound having an action of inhibiting the production of canine erythritine
|
|
US20120122928A1
(en)
|
2010-08-11 |
2012-05-17 |
Bayer Cropscience Ag |
Heteroarylpiperidine and -Piperazine Derivatives as Fungicides
|
|
CN102116772B
(zh)
|
2010-09-28 |
2013-08-28 |
上海大学 |
二氢查尔酮化合物的筛选方法
|
|
JP2014501224A
(ja)
|
2010-12-27 |
2014-01-20 |
武田薬品工業株式会社 |
口腔内崩壊錠
|
|
US9056838B2
(en)
|
2011-04-06 |
2015-06-16 |
Teva Pharmaceutical Industries Ltd. |
Intermediates and processes for preparing Ticagrelor
|
|
KR101952222B1
(ko)
|
2011-04-11 |
2019-02-26 |
그린 테크 가부시키가이샤 |
신규 피라졸 유도체
|
|
MX2014001933A
(es)
|
2011-09-15 |
2014-03-27 |
Demerx Inc |
Ansolvatos de sal de noribogaina.
|
|
WO2013052803A2
(en)
|
2011-10-07 |
2013-04-11 |
Radiorx, Inc. |
Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
|
|
SG11201403645VA
(en)
*
|
2011-12-28 |
2014-07-30 |
Global Blood Therapeutics Inc |
Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
ES2790358T3
(es)
|
2011-12-28 |
2020-10-27 |
Global Blood Therapeutics Inc |
Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular
|
|
JP5906489B2
(ja)
*
|
2012-05-18 |
2016-04-20 |
新日鉄住金化学株式会社 |
ポルフィリン色素並びにポルフィリン色素を用いた色素増感太陽電池及び光電変換素子
|
|
EP2940012B1
(en)
|
2012-12-27 |
2019-01-30 |
Sumitomo Chemical Company Limited |
Tetrazolinone compound and applications thereof
|
|
US9604999B2
(en)
|
2013-03-15 |
2017-03-28 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US20150057251A1
(en)
|
2013-08-26 |
2015-02-26 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
WO2014145040A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
WO2014150256A1
(en)
|
2013-03-15 |
2014-09-25 |
Global Blood Therapeutics, Inc. |
Compositions and methods for the modulation of hemoglobin (s)
|
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
CN105073728A
(zh)
|
2013-03-15 |
2015-11-18 |
全球血液疗法股份有限公司 |
化合物及其用于调节血红蛋白的用途
|
|
EA201591426A1
(ru)
|
2013-03-15 |
2016-02-29 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
|
US9458139B2
(en)
|
2013-03-15 |
2016-10-04 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US9422279B2
(en)
|
2013-03-15 |
2016-08-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
ES2890077T3
(es)
|
2013-03-15 |
2022-01-17 |
Global Blood Therapeutics Inc |
Compuestos y usos de los mismos para la modulación de la hemoglobina
|
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
EP2970184B1
(en)
|
2013-03-15 |
2018-12-05 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US20140271591A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Compositions and methods for the modulation of hemoglobin (s)
|
|
US9802900B2
(en)
|
2013-03-15 |
2017-10-31 |
Global Blood Therapeutics, Inc. |
Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
|
|
US20140274961A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
AP2015008720A0
(en)
|
2013-03-15 |
2015-09-30 |
Global Blood Therapeutics Inc |
Compounds and uses thereof for the modulation of hemoglobin
|
|
WO2015031284A1
(en)
|
2013-08-26 |
2015-03-05 |
Global Blood Therapeutics, Inc. |
Formulations comprising wetting agents and compounds for the modulation of hemoglobin (s)
|
|
US20160207904A1
(en)
|
2013-08-27 |
2016-07-21 |
Global Blood Therapeutics, Inc. |
Crystalline 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde ansolvate salts
|
|
WO2015031285A1
(en)
|
2013-08-27 |
2015-03-05 |
Global Blood Therapeutics, Inc. |
Crystalline 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde ansolvate salts
|
|
US20150141465A1
(en)
|
2013-11-18 |
2015-05-21 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US9248199B2
(en)
|
2014-01-29 |
2016-02-02 |
Global Blood Therapeutics, Inc. |
1:1 adducts of sickle hemoglobin
|
|
WO2015116061A1
(en)
*
|
2014-01-29 |
2015-08-06 |
Global Blood Therapeutics, Inc. |
1:1 adducts of sickle hemoglobin
|
|
PE20160179A1
(es)
|
2014-02-07 |
2016-05-20 |
Global Blood Therapeutics Inc |
Polimorfos cristalinos de la base libre de 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)piridin-3-il)metoxi)benzaldehido
|
|
MA41841A
(fr)
|
2015-03-30 |
2018-02-06 |
Global Blood Therapeutics Inc |
Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
|
|
SG11201804647TA
(en)
|
2015-12-04 |
2018-06-28 |
Global Blood Therapeutics Inc |
Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
|
|
TWI825524B
(zh)
|
2016-05-12 |
2023-12-11 |
美商全球血液治療公司 |
用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
|
|
TW202332423A
(zh)
|
2016-10-12 |
2023-08-16 |
美商全球血液治療公司 |
包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
|